| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |